Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Serum expression of microRNA-21, microRNA-125a, microRNA-125b, microRNA-214 in coronary artery disease patients

View through CrossRef
Background. Coronary artery disease (CAD) is determined by interaction of environmental factors with epigenetic and genetic factors. MicroRNA-21, microRNA-125a, microRNA-125b and microRNA-214 are small non-coding RNAs and the most important regulators of gene expression. MicroRNA-21, -125a, -125b and -214 are insufficiently studied in CAD patients. Objective. To explore serum expression of microRNA-21, microRNA-125a, microRNA-125b, microRNA-214 in CAD patients with different features of clinical course. Material and methods. The study included 129 CAD patients (men 56.6% and women 43.4%) aged 63.17±8.57 years. The comparison group consisted of 45 people without CAD (men 55.6% and women 44.4%) aged 62.09±8.79 years (p>0.05). Serum microRNA expression was analyzed using real-time polymerase chain reaction. Relative microRNA expression was estimated in accordance with standard 2-ΔCt procedure. Results. Serum expression of microRNA-21, microRNA-125a, microRNA-125b and microRNA-214 is higher in CAD patients (p<0.001). MicroRNA-21 expression >16.43 units increases the risk of CAD by 3.49 times (HR 3.49, 95% CI 1.70—7.17, p<0.001), microRNA-125a expression >7.21 units — by 5.18 times (HR 5.18, 95% CI 2.29—11.69, p<0.001), microRNA-125b expression >3.49 units — by 4.03 times (HR 4.03, 95% CI 1.86—8.72, p=0.0001), microRNA-214 expression >2.47 units — by 3.99 times (HR 3.99, 95% CI 1.91—8.37, p<0.001). Expression of microRNA-21 and microRNA-214 was higher in patients with early CAD than in older patients (p<0.05). Expression of microRNA-21, microRNA-125a, microRNA-125b and microRNA-214 was higher in CAD patients with myocardial infarction (MI) than in patients without MI (p<0.05). Conclusion. Expression of microRNA-21, microRNA-125a, microRNA-125b and microRNA-214 was higher in CAD patients than in the comparison group, as well as in CAD patients with MI. Expression of microRNA-21 and microRNA-214 was higher in patients with early CAD than in older patients.
Title: Serum expression of microRNA-21, microRNA-125a, microRNA-125b, microRNA-214 in coronary artery disease patients
Description:
Background.
Coronary artery disease (CAD) is determined by interaction of environmental factors with epigenetic and genetic factors.
MicroRNA-21, microRNA-125a, microRNA-125b and microRNA-214 are small non-coding RNAs and the most important regulators of gene expression.
MicroRNA-21, -125a, -125b and -214 are insufficiently studied in CAD patients.
Objective.
To explore serum expression of microRNA-21, microRNA-125a, microRNA-125b, microRNA-214 in CAD patients with different features of clinical course.
Material and methods.
The study included 129 CAD patients (men 56.
6% and women 43.
4%) aged 63.
17±8.
57 years.
The comparison group consisted of 45 people without CAD (men 55.
6% and women 44.
4%) aged 62.
09±8.
79 years (p>0.
05).
Serum microRNA expression was analyzed using real-time polymerase chain reaction.
Relative microRNA expression was estimated in accordance with standard 2-ΔCt procedure.
Results.
Serum expression of microRNA-21, microRNA-125a, microRNA-125b and microRNA-214 is higher in CAD patients (p<0.
001).
MicroRNA-21 expression >16.
43 units increases the risk of CAD by 3.
49 times (HR 3.
49, 95% CI 1.
70—7.
17, p<0.
001), microRNA-125a expression >7.
21 units — by 5.
18 times (HR 5.
18, 95% CI 2.
29—11.
69, p<0.
001), microRNA-125b expression >3.
49 units — by 4.
03 times (HR 4.
03, 95% CI 1.
86—8.
72, p=0.
0001), microRNA-214 expression >2.
47 units — by 3.
99 times (HR 3.
99, 95% CI 1.
91—8.
37, p<0.
001).
Expression of microRNA-21 and microRNA-214 was higher in patients with early CAD than in older patients (p<0.
05).
Expression of microRNA-21, microRNA-125a, microRNA-125b and microRNA-214 was higher in CAD patients with myocardial infarction (MI) than in patients without MI (p<0.
05).
Conclusion.
Expression of microRNA-21, microRNA-125a, microRNA-125b and microRNA-214 was higher in CAD patients than in the comparison group, as well as in CAD patients with MI.
Expression of microRNA-21 and microRNA-214 was higher in patients with early CAD than in older patients.

Related Results

A study on risk factors of coronary artery disease in Chong Qing city
A study on risk factors of coronary artery disease in Chong Qing city
Objective To investigate the relationship between risk factors and coronary artery disease in Chong Qing city, and to provide scientific basis for preventing and ...
Data from MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway
Data from MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway
<div>Abstract<p>Radioresistance poses a major challenge in nasopharyngeal carcinoma (NPC) treatment, but little is known about how miRNA regulates this phenomenon. In t...
Data from MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway
Data from MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway
<div>Abstract<p>Radioresistance poses a major challenge in nasopharyngeal carcinoma (NPC) treatment, but little is known about how miRNA regulates this phenomenon. In t...
MicroRNA-34, microRNA-130, microRNA-148, microRNA-181, microRNA-194 and microRNA-605 expression in colon cancer tissue
MicroRNA-34, microRNA-130, microRNA-148, microRNA-181, microRNA-194 and microRNA-605 expression in colon cancer tissue
Purpose of the study. Determination of the expression of microRNA‑34, microRNA‑130, microRNA‑148, microRNA‑181, microRNA‑194 and microRNA‑605 in colon tumor tissue depending on the...
PML-Rara/Nrf2-Regulated Mir-125b Targets CEBPA and Influences Acute Promyelocytic Leukemia Cell Proliferation
PML-Rara/Nrf2-Regulated Mir-125b Targets CEBPA and Influences Acute Promyelocytic Leukemia Cell Proliferation
Abstract Acute promyelocytic leukemia (APL) is characterized by the presence of PML-RARA fusion protein. The PML-RARA oncoprotein is known to be the initiating facto...

Back to Top